NPS PHARMACEUTICALS INC - FORM 10-K - EX-12.1 - COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES - March 11, 2010

Attached files

file filename
10-K - 10-K - NPS PHARMACEUTICALS INCform10k.htm
10-K - 10-K - NPS PHARMACEUTICALS INCform10-k.pdf
EX-10.31 - AGREEMENT FOR SALE AND ASSIGNMENT OF RIGHTS, DATED FEBRUARY 26, 2010, BETWEEN NPS PHARMACEUTICALS, INC. AND LSRC II S.?R.L. - NPS PHARMACEUTICALS INCexhibit10-31.pdf
EX-12.1 - COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES - NPS PHARMACEUTICALS INCexhibit12-1.pdf
EX-21.1 - SUBSIDIARIES - NPS PHARMACEUTICALS INCexhibit21-1.pdf
EX-23.1 - CONSENT - NPS PHARMACEUTICALS INCexhibit23-1.pdf
EX-31.1 - CEO 302 CETIFICATE - NPS PHARMACEUTICALS INCexhibit31-1.pdf
EX-31.2 - CEO 302 CETIFICATE - NPS PHARMACEUTICALS INCexhibit31-2.pdf
EX-32.1 - 906 CERTIFICATE - NPS PHARMACEUTICALS INCexhibit32-1.pdf
EX-21.1 - SUBSIDIARIES - NPS PHARMACEUTICALS INCexh21-1.htm
EX-31.2 - CEO 302 CETIFICATE - NPS PHARMACEUTICALS INCexh31-2.htm
EX-32.1 - 906 CERTIFICATE - NPS PHARMACEUTICALS INCexh32-1.htm
EX-31.1 - CEO 302 CETIFICATE - NPS PHARMACEUTICALS INCexh31-1.htm
EX-23.1 - CONSENT - NPS PHARMACEUTICALS INCexh23-1.htm
EX-10.31 - AGREEMENT FOR SALE AND ASSIGNMENT OF RIGHTS, DATED FEBRUARY 26, 2010, BETWEEN NPS PHARMACEUTICALS, INC. AND LSRC II S.?R.L. - NPS PHARMACEUTICALS INCexh10-31.htm

Exhibit 12.1
Statement Regarding Computation of Ratio of Earnings to Fixed Charges
(in thousands)
                               
      Year Ended December 31,
      2005
    2006
    2007
    2008
    2009
Earnings (loss)                              
Pre-tax loss   $ (169,778)   $ (112,668)   $ (3,502)   $ (31,905)   $ (19,606)
Total fixed charges   $ 25,937 
  $ 29,634 
  $ 41,932 
  $ 65,534 
  $ 52,759 
Total income (loss) before fixed charges   $ (143,841)
  $ (83,034)
  $ 38,430 
  $ 33,629 
  $ 33,153 
                               
Fixed Charges                              
Interest expenses   $ 25,119    $ 28,970    $ 41,397    $ 65,373    $ 52,627 
Assumed interest attributable to rentals   $ 818 
  $ 664 
  $ 535 
  $ 161 
  $ 132 
Total fixed charges   $ 25,937 
  $ 29,634 
  $ 41,932 
  $ 65,534 
  $ 52,759 
Deficiency of earnings available to cover fixed charges   $ 169,778 
  $ 112,668 
  $ 3,502 
  $ 31,905 
  $ 19,606 
Ratio of earnings available to cover fixed charges     n/a      n/a      n/a      n/a      n/a 

NPS PHARMACEUTICALS INC Reports